Hemophilia A Gene Therapy Candidate SB-525 Posts Good Early Trial Results
The investigational gene therapy SB-525Â is tolerated well by patients, and dose-dependent responses are positive, according to preliminary results of…
Articles by Diogo Pinto
Irish Medical University and Bayer Partner to Advance Treatments for Hemophilia
The Royal College of Surgeons in Ireland (RCSI) and Bayer will collaborate to develop improved treatments for patients…
Pfizer Launches Phase 3 Program to Test Gene Therapy for Treating Hemophilia B
Pfizer has partnered with Spark Therapeutics to launch a Phase 3 program to evaluate the safety and effectiveness of…